References
- BoseIli E, Allaouchiche B. Diffusion in bone tissue of antibiotics [in French]. Presse Med 1999; 28 (40): 2265–76.
- Sorgel F, Kinzig M. The chemistry, pharmacokinetics and tissue distribution of piperacillin/tazobactam. J Antimicrob Chemother 1993; 31 (Suppl. A): 39-60.
- Souza E, Munoz P. Micro-organisms responsible for osteo-articular infections. Baillieres Best Pract Res Clin Rheumatol 1999; 13 (1): 21–35.
- Kinzig M, Sorgel F, Brismar B, Nord CE. Pharmacokinetics and tissue penetration of tazobactam and piperacillin in patients undergoing colorectal surgery. Antimicrob Agents Chemother 1992; 36 (9): 1997–2004.
- Incavo SJ, Ronchetti PJ, Choi JH, Wu H, Kinzig M, Sorgel F. Penetration of piperacillin-tazobactam into cancel-lous and cortical bone tissues. Antimicrob Agents Chemother 1994; 38 (4): 905–7.
- Ellner PD, Neu HC. The inhibitory quotient. A method for interpreting minimum inhibitory concentration data. JAMA 1981; 246 (14): 1575–8.
- Cormican M, Corbett-Feeney G, Kelly S, Hughes D, Flynn J, Jones RN. In-vitro activity of piperacillin/tazobactam relative to other antibiotics against blood culture isolates. Ir J Med Sci 1998; 167 (3): 155–9.
- Sanders WE Jr, Sanders CC. Piperacillin/tazobactam: a critical review of the evolving clinical literature. Clin Infect Dis 1996; 22 (1): 107–123.
- BoseIli E, Breilh D, Biot L, Bel JC, Saux MC, Allaouchiche B. Penetration of piperacillin/tazobactam into cancellous and cortical bone tissue. Curr Ther Res Clin Exp 2001; 62 (7): 538–45.
- Johnson JS, Freemont AJ. A 10 year retrospective comparison of the diagnostic usefulness of synovial fluid and synovial biopsy examination. J Clin Pathol 2001; 54 (8): 605–7.